Disruption of a single copy of the p38α MAP kinase gene leads to cardioprotection against ischemia–reperfusion
- 28 February 2003
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 302 (1), 56-60
- https://doi.org/10.1016/s0006-291x(03)00096-2
Abstract
No abstract availableKeywords
Funding Information
- Ministerie van Onderwijs, Cultuur en Wetenschap
This publication has 23 references indexed in Scilit:
- Antiischemic Effects of SB203580 Are Mediated Through the Inhibition of p38α Mitogen-Activated Protein KinaseCirculation Research, 2001
- The role of differential activation of p38‐mitogen‐activated protein kinase in preconditioned ventricular myocytesThe FASEB Journal, 2000
- Requirement for p38α in Erythropoietin ExpressionCell, 2000
- Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular DevelopmentMolecular Cell, 2000
- Deficiency of the Stress Kinase P38α Results in Embryonic LethalityThe Journal of Experimental Medicine, 2000
- Ischemic Preconditioning Activates MAPKAPK2 in the Isolated Rabbit HeartCirculation Research, 2000
- Phosphorylation of Tyrosine 182 of p38 Mitogen-activated Protein Kinase Correlates with the Protection of Preconditioning in the Rabbit HeartJournal of Molecular and Cellular Cardiology, 1997
- MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart FailureCell, 1997
- Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat heartsFEBS Letters, 1996
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986